Essex Management, an Emmes Group company, has appointed David Loose as Chief Executive Officer (CEO), effective immediately.

The companies entered the agreement in 2023 to jointly advance as many as 11 drug programs, mainly targeting cardiovascular ...

Increases speed to market for drug developers working on nucleic acid therapeutics.

Mytos, a provider of automated cell manufacturing, has entered a manufacturing collaboration with Aspen Neuroscience, Inc. to ...

Mytos has entered into a manufacturing collaboration with Aspen Neuroscience Inc. to automate the manufacturing of autologous ...

Antag Therapeutics, a biopharmaceutical company pioneering novel treatments for obesity, has appointed Joerg Moeller, MD, PhD ...

NorthStar Medical Radioisotopes, LLC and YAP Therapeutics, Inc. have formed a partnership to develop and manufacture ...

Tarsier Pharma, Ltd, a late-clinical stage ophthalmic biopharmaceutical company focused on developing and commercializing ...

Canyon Labs, a leader in analytical & packaging lab testing and consulting for medical devices and pharmaceuticals, has ...

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostics products, launched Foresight Pro 45 cm inner diameter (ID) chromatography columns, designed to support ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, has adopted Quris’ Bio-AI clinical prediction ...

Orbis Medicines, an oral macrocycle drug discovery company, closed a €90 million Series A funding round, bringing the total ...